Skip to main content

Search

16 result(s) for 'author#Giulio Alessandri' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. In the last years, several clinical trials have proved the safety and efficacy of adipose-derived stem/stromal cells (ASC) in contrasting osteoarthritis (OA). Since ASC act mainly through paracrine mechanisms,...

    Authors: Chiara Giannasi, Stefania Niada, Cinzia Magagnotti, Enrico Ragni, Annapaola Andolfo and Anna Teresa Brini
    Citation: Stem Cell Research & Therapy 2020 11:521
  2. Brain microvascular endothelial cells (BMVECs) constitute the primary limitation for passage of ions and molecules from the blood into the brain through the blood brain barrier. Numerous multi-step procedures ...

    Authors: Stefania Elena Navone, Giovanni Marfia, Sara Nava, Gloria Invernici, Silvia Cristini, Sergio Balbi, Simone Sangiorgi, Emilio Ciusani, Alessandra Bosutti, Giulio Alessandri, Mark Slevin and Eugenio Agostino Parati
    Citation: Vascular Cell 2013 5:10

    The Related Article to this article has been published in Nature Protocols 2013 8:nprot.2013.107

  3. The study aimed to evaluate the permanence of resin and enamel remains on lingual brackets at the end of orthodontic treatment and after the debonding procedure. The evaluation of resin remnants on customized ...

    Authors: Can Kuskonmaz, Alberto De Stefani, Gilberto Artioli, Matteo Zanarini, Giulio Alessandri Bonetti, Giovanni Bruno and Antonio Gracco
    Citation: BMC Oral Health 2020 20:142
  4. Human adipose-derived stromal cells (hASCs), due to their relative feasibility of isolation and ability to secrete large amounts of angiogenic factors, are being evaluated for regenerative medicine. However, t...

    Authors: Luigi Balducci, Antonella Blasi, Marilisa Saldarelli, Antonio Soleti, Augusto Pessina, Arianna Bonomi, Valentina Coccè, Marta Dossena, Valentina Tosetti, Valentina Ceserani, Stefania Elena Navone, Maria Laura Falchetti, Eugenio Agostino Parati and Giulio Alessandri
    Citation: Stem Cell Research & Therapy 2014 5:63
  5. Reproducibility of a research is a key element in the modern science and it is mandatory for any industrial application. It represents the ability of replicating an experiment independently by the location and...

    Authors: Neha Kulkarni, Luca Alessandrì, Riccardo Panero, Maddalena Arigoni, Martina Olivero, Giulio Ferrero, Francesca Cordero, Marco Beccuti and Raffaele A. Calogero
    Citation: BMC Bioinformatics 2018 19(Suppl 10):349

    This article is part of a Supplement: Volume 19 Supplement 10

  6. Mesenchymal stem cells (MSCs) are multipotent stem cells able to differentiate into different cell lineages. However, MSCs represent a subpopulation of a more complex cell composition of stroma cells contained...

    Authors: Antonella Blasi, Carmela Martino, Luigi Balducci, Marilisa Saldarelli, Antonio Soleti, Stefania E Navone, Laura Canzi, Silvia Cristini, Gloria Invernici, Eugenio A Parati and Giulio Alessandri
    Citation: Vascular Cell 2011 3:5
  7. Adipose-derived mesenchymal stromal cells (Ad-MSCs) are a promising tool for advanced cell-based therapies. They are routinely obtained enzymatically from fat lipoaspirate (LP) as SVF, and may undergo prolonged e...

    Authors: Valentina Ceserani, Anna Ferri, Angiola Berenzi, Anna Benetti, Emilio Ciusani, Luisa Pascucci, Cinzia Bazzucchi, Valentina Coccè, Arianna Bonomi, Augusto Pessina, Erica Ghezzi, Offer Zeira, Piero Ceccarelli, Silvia Versari, Carlo Tremolada and Giulio Alessandri
    Citation: Vascular Cell 2016 8:3
  8. Silk fibroin (SF) scaffolds have been shown to be a suitable substrate for tissue engineering and to improve tissue regeneration when cellularized with mesenchymal stromal cells (MSCs). We here demonstrate, fo...

    Authors: Stefania Elena Navone, Luisa Pascucci, Marta Dossena, Anna Ferri, Gloria Invernici, Francesco Acerbi, Silvia Cristini, Gloria Bedini, Valentina Tosetti, Valentina Ceserani, Arianna Bonomi, Augusto Pessina, Giuliano Freddi, Antonio Alessandrino, Piero Ceccarelli, Rolando Campanella…
    Citation: Stem Cell Research & Therapy 2014 5:7
  9. Biglycan is an important proteoglycan of the extracellular matrix of intervertebral disc (IVD), and its decrease with aging has been correlated with IVD degeneration. Biglycan deficient (Bgn−/0) mice lack this pr...

    Authors: Giovanni Marfia, Rolando Campanella, Stefania Elena Navone, Ileana Zucca, Alessandro Scotti, Matteo Figini, Clara Di Vito, Giulio Alessandri, Laura Riboni and Eugenio Parati
    Citation: Arthritis Research & Therapy 2014 16:457
  10. In the context of drug delivery, mesenchymal stromal cells (MSCs) from bone marrow and adipose tissue have emerged as interesting candidates due to their homing abilities and capacity to carry toxic loads, whi...

    Authors: Arianna Bonomi, Antonietta Silini, Elsa Vertua, Patrizia Bonassi Signoroni, Valentina Coccè, Loredana Cavicchini, Francesca Sisto, Giulio Alessandri, Augusto Pessina and Ornella Parolini
    Citation: Stem Cell Research & Therapy 2015 6:155
  11. Mesenchymal stem/stromal cells (MSCs) represent an attractive tool for cell-based cancer therapy mainly because of their ability to migrate to tumors and to release bioactive molecules. However, the impact of ...

    Authors: Simone Pacioni, Quintino Giorgio D’Alessandris, Stefano Giannetti, Liliana Morgante, Valentina Coccè, Arianna Bonomi, Mariachiara Buccarelli, Luisa Pascucci, Giulio Alessandri, Augusto Pessina, Lucia Ricci-Vitiani, Maria Laura Falchetti and Roberto Pallini
    Citation: Stem Cell Research & Therapy 2017 8:53
  12. Mesenchymal stromal cells (MSCs) are considered an important therapeutic tool in cancer therapy. They possess intrinsic therapeutic potential and can also be in vitro manipulated and engineered to produce therape...

    Authors: Augusto Pessina, Carlo Leonetti, Simona Artuso, Anna Benetti, Enrico Dessy, Luisa Pascucci, Daniela Passeri, Augusto Orlandi, Angiola Berenzi, Arianna Bonomi, Valentina Coccè, Valentina Ceserani, Anna Ferri, Marta Dossena, Pietro Mazzuca, Emilio Ciusani…
    Citation: Journal of Experimental & Clinical Cancer Research 2015 34:82
  13. The goal of cancer chemotherapy is targeting tumor cells and/or tumor-associated microvessels with the lowest systemic toxicity. Mesenchymal stromal cells (MSCs) are promising vehicles for selective drug deliv...

    Authors: Simone Pacioni, Quintino Giorgio D’Alessandris, Stefano Giannetti, Liliana Morgante, Ivana De Pascalis, Valentina Coccè, Arianna Bonomi, Luisa Pascucci, Giulio Alessandri, Augusto Pessina, Maria Laura Falchetti and Roberto Pallini
    Citation: Stem Cell Research & Therapy 2015 6:194
  14. Mesenchymal stem cell (MSC) therapy is considered one of the most promising approaches for treating different neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). We previously character...

    Authors: Laura Canzi, Valeria Castellaneta, Stefania Navone, Sara Nava, Marta Dossena, Ileana Zucca, Tiziana Mennini, Paolo Bigini and Eugenio A Parati
    Citation: Molecular Medicine 2011 18:1803401